JDRF welcomes Walmart’s announcement regarding their plan to offer lower-cost insulin. Walmart, working directly with Novo Nordisk, will launch ReliOn Novolog in both vials and FlexPens. The vial will retail for $72.88 and the FlexPens for $85.88 which, according to the announcement from Walmart, represents a 58% and 75% discount compared to other insulin products.
↧